A selective Na V 1.1 activator with potential for treatment of Dravet syndrome epilepsy.

MLA

Chow, Chun Yuen, et al. “A Selective Na V 1.1 Activator with Potential for Treatment of Dravet Syndrome Epilepsy.” Biochemical Pharmacology, vol. 181, Nov. 2020, p. 113991. EBSCOhost, https://doi.org/10.1016/j.bcp.2020.113991.

APA

Chow, C. Y., Chin, Y. K. Y., Ma, L., Undheim, E. A. B., Herzig, V., & King, G. F. (2020). A selective Na V 1.1 activator with potential for treatment of Dravet syndrome epilepsy. Biochemical Pharmacology, 181, 113991. https://doi.org/10.1016/j.bcp.2020.113991

Chicago

Chow, Chun Yuen, Yanni K Y Chin, Linlin Ma, Eivind A B Undheim, Volker Herzig, and Glenn F King. 2020. “A Selective Na V 1.1 Activator with Potential for Treatment of Dravet Syndrome Epilepsy.” Biochemical Pharmacology 181 (November): 113991. doi:10.1016/j.bcp.2020.113991.